| Sheila Ann Ventura, | |
|
2010 S Fry Rd, Katy, TX 77450-5290 | |
| (281) 398-9628 | |
| (281) 398-1002 |
| Full Name | Sheila Ann Ventura |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2010 S Fry Rd, Katy, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083942189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 35784 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sheila Ann Ventura, 2010 S Fry Rd, Katy, TX 77450-5290 Ph: (281) 398-9628 | Sheila Ann Ventura, 2010 S Fry Rd, Katy, TX 77450-5290 Ph: (281) 398-9628 |
News Archive
Using an advanced three-dimensional mapping technique developed by UCLA researchers, the team analyzed magnetic resonance imaging data from 24 patients with amnestic mild cognitive impairment (MCI) and 25 others with mild Alzheimer's disease.
The researchers looked at 239 employees from 20 in-store bakeries for a supermarket chain. They collected data from questionnaires on a number of respiratory symptoms including chest tightness, breathing difficulties, chest wheezing or whistling, running or itchiness of the nose and eyes and sneezing. They also used skin prick tests to check for allergies associated with baking.
The heart needs a steady supply of energy to function properly. MUHC researcher Dr. Vincent Gigure's and his colleagues recently identified several genetic programs which work together to ensure this energy is available.
As the new administration considers the future direction of the Food and Drug Administration, a group of leading researchers has created a Blueprint for Transparency at the agency to advance the development of safe and effective new products.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Diovan (valsartan), the most prescribed ARB (angiotensin receptor blocker) in the US and worldwide, for a new indication to reduce cardiovascular death in patients at high risk (with left ventricular failure or left ventricular dysfunction) following a heart attack.
› Verified 5 days ago
Dr. Tiffany Buu Ho, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5161 Franz Rd, Katy, TX 77493 Phone: 281-391-3410 | |
Dr. Toan Phan, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9423 Spring Green Blvd, Katy, TX 77494 Phone: 281-712-4084 | |
Dr. Himani Patel, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22850 Morton Ranch Rd, Katy, TX 77449 Phone: 346-307-8161 | |
Michel Morgan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5161 Franz Rd, Katy, TX 77493 Phone: 281-391-3410 | |
Tiffany Khong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2720 Fm 1463 Rd, Katy, TX 77494 Phone: 281-769-9255 | |
Brendan Gonsalves, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5161 Franz Rd, Katy, TX 77493 Phone: 281-391-3410 | |
Aaron Moniotte, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23331 Grand Reserve Dr, Katy, TX 77494 Phone: 281-505-3572 |